Nasdaq: KURAa clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported updated preliminary results from a Phase 2 clinical trial of its lead product candidate, tipifarnib, in squamous cell carcinomas with HRAS mutations. Kura Oncology, a biopharmaceutical company, advances a pipeline of Regions Greater San Diego Area, West Coast, Western US Founded Date Dating kura ng san diego.
In that regard, we are encouraged by preliminary signals of clinical activity observed in patients with HRAS mutant SCCs as we believe this may represent a near-term opportunity to expand the use of tipifarnib into a broader set of HRAS mutant cancers. Kura will use reasonable efforts to include accurate and up-to-date information on this Kura website and Kura's social media offerings, . San Diego, CA . Kura has granted the underwriters a day option to purchase up to an additionalshares of its common stock.
Kura Oncology, Inc. KURAa clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced that the U. Patent and Trademark Office USPTO has issued and the European Patent Office has granted new patents further protecting the Company's lead drug candidate, tipifarnib, a potent and selective farnesyl transferase inhibitor. Tipifarnib is currently being studied in multiple solid tumor and hematologic indications, including a registration-directed clinical trial in HRAS mutant head and neck squamous cell carcinoma HNSCC.
Watch the tempting small plates travel past your table. Photo of Kura Revolving Sushi Bar - San Diego, CA, United States. Photo of Kura .. The cutest place to go with friends or on a date. It is very kid friendly too.
Kula Revolving Sushi Bar, San Diego: See 72 unbiased reviews of Kula 4 of 5 on TripAdvisor and ranked # of restaurants in San Diego. Date of visit : March . Worth a Visit & Fun for Kids (Kula Sushi is now Kura Sushi).
October 22, ET | Source: Kura Oncology, Inc. MUNICH, Germany and SAN DIEGO, Oct. 22, (GLOBE NEWSWIRE) -- Kura Oncology, Inc. As of the September 7, clinical data cutoff date, 17 patients.
SAN DIEGO, Nov. 05, (GLOBE NEWSWIRE) -- Kura Oncology, Inc., ( Nasdaq: KURA) a clinical-stage biopharmaceutical company focused.